FDA Approved: RYKINDO EXTENDED-RELEASE MICROSPHERES — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for RyKindo Extended-Release Microspheres, a new extended-release formulation of risperidone developed by Shandong Luye …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• RYKINDO EXTENDED-RELEASE MICROSPHERES (risperidone)

Snippet

SUPPL AP for RYKINDO EXTENDED-RELEASE MICROSPHERES (RISPERIDONE)